Clinical Trial Update: Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy of botulinum toxin type A injections for cervicobrachial neuralgia and myofascial pain syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervicobrachial Neuralgia
• Myofascial Pain Syndromes

Drugs mentioned

• Botulinum toxin type A injections (onabotulinumtoxinA)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cervicobrachial Neuralgia, Myofascial Pain Syndromes | Phase 4 | Status: COMPLETED